mo farah l carnitine BBC Panorama investigation questions Farah's use of L-carnitine injections under former coach, Alberto Salazar Mo Farah, Alberto Salazar and

Understanding biomarker context and provider-guided expectations helps patients make informed decisions about this peptide therapy

People have claimed that it heals joints, fixes gut problems, and even sharpens their minds with minimal side effects

Rheumatology 54 (2), 363368

Unlike current single (GLP-1) and dual (GLP-1/GIP) agonist compounds like Semaglutide and Tirzepatide , Retatrutide is a triple agonist compound targeting three hormone receptors instead of only one or two: GLP-1 (glucagon-like peptide-1) GIP (glucose-dependent insulinotropic polypeptide) GCG (glucagon receptor) According to a landmark clinical trial published in the New England Journal of Medicine , Retatrutide demonstrated significant weight reduction, up to 30%, in participants over a 48-week period, highlighting its potential as a next-generation metabolic peptide